Protein kinase C isoforms as therapeutic targets in nervous system disease states.
about
Nitric oxide and peroxynitrite in health and diseaseEstablishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural NootropicInterplay between cell migration and neurite outgrowth determines SH2B1β-enhanced neurite regeneration of differentiated PC12 cellsProtein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling.Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury.Perspectives on reperfusion-induced damage in rodent models of experimental focal ischemia and role of gamma-protein kinase C.PKCε and allopregnanolone: functional cross-talk at the GABAA receptor levelPathophysiology of depression and mechanisms of treatmentIdentifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation.A model for dynamic regulation of choline acetyltransferase by phosphorylation.Post-translational modifications of voltage-gated sodium channels in chronic pain syndromesDOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortexThe "ups and downs" of signaling cascades in addiction.PKC in Regenerative Therapy: New Insights for Old Targets.Neurochemical targets and behavioral effects of organohalogen compounds: an update.Current clinical trials in amyotrophic lateral sclerosis.Intracellular signaling pathways pave roads to recovery for mood disorders.Phosphatidylinositide 3-kinase and protein kinase C zeta mediate retinoic acid induction of DARPP-32 in medium size spiny neurons in vitroProtein kinase C activity is associated with prefrontal cortical decline in agingThe role of protein kinase C epsilon in neural signal transduction and neurogenic diseases.Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats.Design and synthesis of triarylacrylonitrile analogues of tamoxifen with improved binding selectivity to protein kinase C.Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells.Rottlerin protected dopaminergic cell line from cytotoxicity of 6-hydroxydopamine by inhibiting PKCdelta phosphorylation.Protein kinase C isoforms differentially phosphorylate human choline acetyltransferase regulating its catalytic activity.Disruption of astrocytic glutamine turnover by manganese is mediated by the protein kinase C pathway.PKCdelta-dependent cleavage and nuclear translocation of annexin A1 by phorbol 12-myristate 13-acetate.Protein kinase C delta cleavage initiates an aberrant signal transduction pathway after cardiac arrest and oxygen glucose deprivation.Nerve growth factor promotes the survival of sympathetic neurons through the cooperative function of the protein kinase C and phosphatidylinositol 3-kinase pathways.
P2860
Q24645400-26AA7B49-F2B2-4B56-9C2A-7B75604A1C7BQ28071703-88624E96-FF23-40FD-9B5B-337EF18A95ACQ31059372-540EF2A6-2A4C-490B-91A8-86BD057B61D0Q34715589-DE5A4901-551B-4954-8D73-5FB9A78FE8A1Q35062604-250781BB-1E52-42F6-8A50-51C0270781A5Q35090277-8FD8F416-1E47-4F9D-9AC8-4C2DA742B337Q35194445-49A4D473-9361-4CD6-A986-8BC6E791769AQ35236438-0A34B724-FE66-46B9-A05C-B70431F8777FQ35557270-4F3E98BD-B542-4D1F-BDED-472F3E80B4AAQ36245818-90C63E1B-18A2-42BD-896A-657680CBF93DQ36249467-1F702CB0-81CF-428B-A6FC-E08DC0D5B8F2Q36301628-FCA3DD42-F727-4109-8C61-88CC81AF5D8AQ36309741-4346CC3F-3C32-46C4-A1A4-5ABD89FAD032Q36376317-F71B0DBE-E27D-400E-ABFE-7C62E3B538C8Q36473995-901301F9-9C3F-42AC-98A1-3A014AE641FEQ36904850-4A40DDC7-0D8E-43BA-83FA-9D7182110310Q36939418-AC608AA8-6B47-4D28-8E9A-FC5C74B53D60Q36954085-F6FCF3F9-E72A-4FF9-A9FC-0F8C000464F9Q37264584-0E247112-685B-4B34-8C96-05F8E887C7C2Q37890957-13310FC2-E1DF-45DB-9C94-B881B4131B3BQ38310789-0E59C619-64E4-4464-B72D-68F4ED741487Q38744832-6794D23F-AA8A-4C29-A5B5-863253085E4FQ39084131-CF58B2D2-712C-4237-A6F8-AB8A8DF8F589Q39820474-BDC57B62-F240-4E72-98E6-3CABE65B7C2EQ40513109-502345B4-C6BA-4456-929B-BF44353150BFQ42728401-9E770D82-F898-49AA-B2B2-44616307C985Q44602443-62C971D2-3567-4325-B0F0-9C7E52AA2B44Q45270331-5B68AA9E-0498-4628-B9AA-F00452638EB4Q47673134-4C90F7C9-BB10-4D88-891C-CF4CA86F2FA4
P2860
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
@ast
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
@en
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
@nl
type
label
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
@ast
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
@en
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
@nl
prefLabel
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
@ast
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
@en
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
@nl
P356
P1476
Protein kinase C isoforms as therapeutic targets in nervous system disease states.
@en
P2093
F Battaini
P304
P356
10.1006/PHRS.2001.0893
P577
2001-11-01T00:00:00Z